Cigna’s PBM Express Scripts sues the FTC, seeking retraction of drug-cost report
Private Companies
No results found
- All News
- Articles
- Video
- Podcasts
FTC’s report said industry middlemen inflate drug costs and squeeze independent pharmacies
Last Updated: First Published:
Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the agency’s July report on the PBM industry was biased and defamatory and asking the court to order the FTC to withdraw the report.
The report is “seventy-four pages of unsupported innuendo leveled against Express Scripts and other PBMs,” Express Scripts alleged in its complaint, filed in federal court in the Eastern District of Missouri. The FTC “disregarded the millions of documents and terabytes of data” produced by PBMs, relying instead on “unverified comments” from companies that PBMs negotiate against when working to lower drug costs, the suit alleged.
Partner Center
Most Popular
About the Author
Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET . All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.